glp-1 molecule How Receptor Agonists Evolved from Diabetes Treatments to Weight Loss Treatments The challenge of developing oral

Figure 31: Photograph of Professor Bernard Thorens, credit Center for Integrative Genomics, University of Lausanne

and limiting distribution of unsafe, non FDA-approved semaglutide

semaglutide GLP-1 addresses the bodys resistance to burning calories by combating factors such as slowed metabolism and hunger-inducing hormones

Transdermal delivery of GLP-1 medications faces significant challenges due to the large molecular size of GLP-1 analogs and the skin's natural barrier function

Some individuals may feel less hungry within a few days, while others may take several weeks before experiencing substantial changes

But with the desire for even greater convenience, a new question is emerging: What about a patch